| [1] |
Liu Debin, Chen Xiaopu, Chen Wenjie, Huang Yinting, He Wenzhen.
Relations between aspirin & clopidogrel resistance-relatedgene polymorphisms and corresponding recurrent cerebral infarction
[J]. Clinical Focus, 2022, 37(4): 320-324.
|
| [2] |
Jiang Yan, Li Jiayang, Wu Hongyu, Chen Baolin, Cheng Xiaoming, Lyu Junyuan.
MDM4rs4245739 gene polymorphism and breast cancer susceptibility:A meta-analysis
[J]. Clinical Focus, 2022, 37(11): 977-984.
|
| [3] |
Wang Shimeng, Ma Yingji, Wu Ying, Liu Xiaodan, Wang Wei.
Effects of HBV infection on liver metastasis of tumor: A meta-analysis
[J]. Clinical Focus, 2021, 36(5): 389-394.
|
| [4] |
Wang Yuanyuan, Cheng Ning, Lin Haiyan.
Correlation of serum sST2 and liver function, platelet level and Ishak score in chronic hepatitis B patients
[J]. Clinical Focus, 2021, 36(11): 976-980.
|
| [5] |
Wang Xiaoling, Shen Lixian, Li Huiwen, Zhang Yaqin, Li Yao, Wu Shuna.
Changes and significance of CD86 expression on pDCs in patients with acute hepatitis B
[J]. Clinical Focus, 2020, 35(8): 719-723.
|
| [6] |
Hu Jian, Dan Xia, Liu Dan, Xu Chunmei, Du Longting, Yang Bing.
Characteristics of etiology and predisposing factors of acute ischemic stroke in Yi and Han nationalities of Liangshan Prefecture
[J]. Clinical Focus, 2020, 35(8): 707-710.
|
| [7] |
Nian Shiyana, Feng Leib.
Difference of cardiovascular biochemical indicators among Dai, Hani and Yi in Yuanjiang county of Yunnan Province
[J]. Clinical Focus, 2020, 35(8): 689-692.
|
| [8] |
Zhu Ping1, Lu Yufeng2a, Wang Li3, Wang Hong2b, Yang Li2b, .
Association study between liver inflammation and HBeAg quantification
[J]. Clinical Focus, 2019, 34(7): 637-640.
|
| [9] |
Dai Rufen, Li Xianli, Li Liyun, Li Li, Li Xiuping, Duan Zhizhen.
Comparative study on the risk factors of OSAHS patients with different severity betweent Bai and Han ethnic groups
[J]. Clinical Focus, 2018, 33(11): 962-965.
|
| [10] |
Xu Manman1, Cheng Kailiang2, Qiu Qian3, Zhao Xinyu2, Duan Zhongping1, Wang Li2, Chen Yu1.
Factors associated with adherence to antiviral therapy in patients with HBV-related cirrhosis
[J]. Clinical Focus, 2018, 33(11): 950-955.
|
| [11] |
Liu Xiaomeng， Zhao Caiyan.
Clinical advances in infectious diseases in 2017
[J]. Clinical Focus, 2018, 33(1): 60-65.
|
| [12] |
Xiong Liangwei， Zhang Xianggui， Zhang Wei， Tang Jieyin.
Effectiveness and safety on immunosuppressant combined with nucleoside analogues therapy in hepatitis B virusassociated glomerulonephritis patients：a metaanalysis
[J]. Clinical Focus, 2017, 32(7): 613-617.
|
| [13] |
Sun Hui，Zhao Caiyan.
Related issues of antiviral treatment of chronic hepatitis B patients during fertile period
[J]. Clinical Focus, 2016, 31(7): 705-709.
|
| [14] |
Li Jun，Han Tao.
2015 Chinese Practice Guidelines of Chronic Hepatitis B: an update
[J]. Clinical Focus, 2016, 31(7): 701-704.
|
| [15] |
Shen Chuan1， Wang Jing2， Zhao Caiyan1， Zhang Wenhong2.
Functional cure of chronic hepatitis B: current status and perspectives
[J]. Clinical Focus, 2016, 31(7): 697-700.
|
